Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide study

Karin Melsens, Maurizio Cutolo, Dieneke Schonenberg-Meinema, Ivan Foeldvari, Maria C Leone, Yora Mostmans, Valérie Badot, Rolando Cimaz, Joke Dehoorne, Ellen Deschepper, Tracy Frech, Johanna Hernandez-Zapata, Francesca Ingegnoli, Archana Khan, Dorota Krasowska, Hartwig Lehmann, Ashima Makol, Miguel A Mesa-Navas, Malgorzata Michalska-Jakubus, Ulf Müller-LadnerLaura Nuño-Nuño, Rebecca Overbury, Carmen Pizzorni, Mislav Radic, Divya Ramadoss, Angelo Ravelli, Silvia Rosina, Clara Udaondo, Merlijn J van den Berg, Ariane L Herrick, Alberto Sulli, Vanessa Smith, Liselotte Deroo, Amber Vanhaecke, Sandy Bergkamp, Amara Nassar-Sheikh-Rashid, Patrone Elisa, Walter Hermann, Francesco Bica, Francesco Cattelan, Maurizio Gattinara, Zeynep Özcan, Sara Murias, Rosa Alcobendas, Augustin Remesal, Pallavi Pimpale, Raju Khubchandani

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

Objectives: To standardly assess and describe nailfold videocapillaroscopy (NVC) assessment in children and adolescents with juvenile rheumatic and musculoskeletal diseases (jRMD) vs healthy controls (HCs). Material and methods: In consecutive jRMD children and matched HCs from 13 centres worldwide, 16 NVC images per patient were acquired locally and read centrally per international consensus standard evaluation of the EULAR Study Group on Microcirculation in Rheumatic Diseases. A total of 95 patients with JIA, 22 with JDM, 20 with childhood-onset SLE (cSLE), 13 with juvenile SSc (jSSc), 21 with localized scleroderma (lSc), 18 with MCTD and 20 with primary RP (PRP) were included. NVC differences between juvenile subgroups and HCs were calculated through multivariable regression analysis. Results: A total of 6474 images were assessed from 413 subjects (mean age 12.1 years, 70.9% female). The quantitative NVC characteristics were significantly lower or higher in the following subgroups compared with HCs: for density: lower in jSSc, JDM, MCTD, cSLE and lSc; for dilations: higher in jSSc, MCTD and JDM; for abnormal shapes: higher in JDM and MCTD; for haemorrhages: higher in jSSc, MCTD, JDM and cSLE. The qualitative NVC assessment of JIA, lSc and PRP did not differ from HCs, whereas the cSLE and jSSc, MCTD, JDM and cSLE subgroups showed more non-specific and scleroderma patterns, respectively. Conclusions: This analysis resulted from a pioneering registry of NVC in jRMD. The NVC assessment in jRMD differed significantly from HCs. Future prospective follow-up will further elucidate the role of NVC in jRMD. VC The Author(s) 2022.

Original languageEnglish
Pages (from-to)1605-1615
Number of pages11
JournalRheumatology
Volume62
Issue number4
DOIs
Publication statusPublished - 3 Apr 2023
Externally publishedYes

Bibliographical note

Funding Information:
V.S. is a senior clinical investigator of the Research Foundation-Flanders (Belgium) (FWO) (1.8.029.20N). The FWO was not involved in the study design; collection, analysis and interpretation of data; writing of the report or the decision to submit the manuscript for publication. She is supported by an unrestricted educational chair on systemic sclerosis from Janssen-Cilag NV. Janssen-Cilag NV was not involved in the study design; collection, analysis and interpretation of data; writing of the report or the decision to submit the manuscript for publication. M.C.L. was a research fellow who received a EULAR scientific training bursary during the data acquisition period of the study.

Publisher Copyright:
© 2023 Oxford University Press. All rights reserved.

Cite this